Sanara MedTech (NASDAQ:SMTI) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $0.11 by 218.18 percent. This is a 230 percent decrease over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $27.546 million which beat the analyst consensus estimate of $27.400 million by 0.53 percent. This is a 4.72 percent increase over sales of $26.305 million the same period last year.